LncRNA HAR1A通过降低c-MYC转录的调节和促进其蛋白质体降解来抑制非小细胞肺癌的生长
Jianqun Ma1, Ping Zhang2, Yuning Wang2
1Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150040, Heilongjiang, China.
International immunopharmacology
|September 28, 2024
概括
长非编码RNA HAR1A抑制非小细胞肺癌 (NSCLC) 的生长,并通过抑制MYC/HSP90β途径增强化疗,为NSCLC治疗提供潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因.
- 长非编码RNAs (lncRNAs) 参与NSCLC的发展和进展,作为潜在的生物标志物和治疗点.
- HAR1A此前已被确定为NSCLC中的抑制瘤的lncRNA,但其精确的机制仍未得到充分探索.
研究的目的:
- 阐明HAR1A在NSCLC中的功能作用和分子机制.
- 研究HAR1A对NSCLC细胞行为和化学敏感性的影响.
- 探索HAR1A作为NSCLC治疗点的潜力.
主要方法:
- 研究了HAR1A调制对NSCLC细胞增殖,迁移,细胞亡和对西斯普拉丁敏感性的影响.
- 利用分子技术检查HAR1A与MYC的相互作用及其下游目标,包括HSP90AB1 (HSP90β).
- 使用裸体小鼠NSCLC异种移植模型进行了体内实验,以评估HAR1A的治疗潜力.
主要成果:
- 增加的HAR1A水平抑制了NSCLC细胞的增殖和迁移,诱导了亡,并增强了对西斯普拉丁的敏感性.
- HAR1A通过降低MYC的调节来抑制自适应性自,影响其转录和蛋白质水平.
- 通过MYC/HSP90β轴,HAR1A减轻了NSCLC的进展和亡,HAR1A过度表达改善了体内西斯普拉丁的疗效.
结论:
- 在NSCLC中,HAR1A通过抑制MYC/HSP90β途径作为瘤抑制剂,从而限制增殖,迁移和自适应性自.
- 哈尔1A增强了西斯的疗效,表明其作为治疗标和NSCLC化疗结果的预测生物标记物的潜力.
- 这项研究为NSCLC中lncRNA介导的化学抵抗机制提供了新的见解,突出了基于lncRNA的癌症治疗的前景.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:20Types of RNA
5.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.7K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K